title: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.
abstract: Acetaminophen (APAP) overdose is a major cause of acute liver failure and serves as a paradigm to elucidate mechanisms, predisposing factors and therapeutic interventions. The roles of apoptosis and inflammation during APAP hepatotoxicity remain controversial. We investigated whether fasting of mice for 24 h can inhibit APAP-induced caspase activation and apoptosis through the depletion of basal ATP. We also investigated in fasted mice the critical role played by inhibition of caspase-dependent cysteine 106 oxidation within high mobility group box-1 protein (HMGB1) released by ATP depletion in dying cells as a mechanism of immune activation. In fed mice treated with APAP, necrosis was the dominant form of hepatocyte death. However, apoptosis was also observed, indicated by K18 cleavage, DNA laddering and procaspase-3 processing. In fasted mice treated with APAP, only necrosis was observed. Inflammatory cell recruitment as a consequence of hepatocyte death was observed only in fasted mice treated with APAP or fed mice cotreated with a caspase inhibitor. Hepatic inflammation was also associated with loss in detection of serum oxidized-HMGB1. A significant role of HMGB1 in the induction of inflammation was confirmed with an HMGB1-neutralizing antibody. The differential response between fasted and fed mice was a consequence of a significant reduction in basal hepatic ATP, which prevented caspase processing, rather than glutathione depletion or altered APAP metabolism. Thus, the inhibition of caspase-driven apoptosis and HMGB1 oxidation by ATP depletion from fasting promotes an inflammatory response during drug-induced hepatotoxicity/liver pathology.
authors.affiliation: Medical Research Council Centre for Drug Safety Science Department of Pharmacology and Therapeutics, Institute for Translational Medicine, University of Liverpool, Liverpool, UK. d.antoine@liv.ac.uk.
authors.forename: Daniel James
authors.initials: DJ
authors.lastname: Antoine
authors.forename: Dominic P
authors.initials: DP
authors.lastname: Williams
authors.forename: Anja
authors.initials: A
authors.lastname: Kipar
authors.forename: Hugh
authors.initials: H
authors.lastname: Laverty
authors.forename: B Kevin
authors.initials: BK
authors.lastname: Park
mesh_terms: D000082:Acetaminophen / Q000009:adverse effects*; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D053148:Caspase 3 / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism*; D004032:Diet; D005978:Glutathione / Q000378:metabolism; D024243:HMGB1 Protein / Q000378:metabolism*; D022781:Hepatocytes / Q000473:pathology; D007249:Inflammation / Q000378:metabolism; D008297:Male; D051379:Mice; D009336:Necrosis / Q000473:pathology; D010084:Oxidation-Reduction
chemical_list: D024243:HMGB1 Protein; D000082:Acetaminophen; D000255:Adenosine Triphosphate; D053148:Caspase 3; D005978:Glutathione
references.citation: Gastroenterology. 2003 Feb;124(2):494-503
references.pmid: 12557154
references.citation: Hepatology. 2006 Feb;43(2 Suppl 1):S31-44
references.pmid: 16447272
references.citation: Biochem Pharmacol. 1995 Jul 17;50(2):155-61
references.pmid: 7632158
references.citation: J Biol Chem. 2004 Feb 27;279(9):7370-7
references.pmid: 14660645
references.citation: Toxicol Appl Pharmacol. 1981 Aug;60(1):66-77
references.pmid: 7281177
references.citation: JAMA. 1994 Dec 21;272(23):1845-50
references.pmid: 7990219
references.citation: J Pharmacol Exp Ther. 1996 Dec;279(3):1470-83
references.pmid: 8968373
references.citation: FASEB J. 2002 Aug;16(10):1227-36
references.pmid: 12153990
references.citation: World J Gastroenterol. 2006 Dec 21;12(47):7666-70
references.pmid: 17171797
references.citation: Toxicol Pathol. 1996 Mar-Apr;24(2):181-9
references.pmid: 8992608
references.citation: J Pharmacol Exp Ther. 2007 Sep;322(3):1208-20
references.pmid: 17556636
references.citation: Carcinogenesis. 1990 May;11(5):847-53
references.pmid: 2139818
references.citation: J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S49-52
references.pmid: 17567465
references.citation: Clin Liver Dis. 2007 Aug;11(3):459-75, v
references.pmid: 17723915
references.citation: J Exp Med. 2000 Aug 21;192(4):565-70
references.pmid: 10952726
references.citation: Proc Natl Acad Sci U S A. 1984 Mar;81(5):1327-31
references.pmid: 6424115
references.citation: Science. 1999 Jul 9;285(5425):248-51
references.pmid: 10398600
references.citation: Biochem Biophys Res Commun. 2003 Apr 25;304(1):207-12
references.pmid: 12705907
references.citation: Immunity. 2008 Jul 18;29(1):21-32
references.pmid: 18631454
references.citation: Toxicol Sci. 2009 Dec;112(2):521-31
references.pmid: 19783637
references.citation: Toxicol Pathol. 2010 Feb;38(2):280-6
references.pmid: 20097795
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1269-79
references.pmid: 16439473
references.citation: J Exp Med. 1997 Apr 21;185(8):1481-6
references.pmid: 9126928
references.citation: Liver. 1988 Dec;8(6):337-43
references.pmid: 3146008
references.citation: BMJ. 2004 Nov 6;329(7474):1076
references.pmid: 15516343
references.citation: Physiol Genomics. 2004 Apr 13;17(2):230-44
references.pmid: 14762175
references.citation: Am J Physiol. 1994 Jul;267(1 Pt 1):C67-74
references.pmid: 8048493
references.citation: Cancer Res. 1997 May 15;57(10):1835-40
references.pmid: 9157970
references.citation: J Immunol. 2008 Feb 15;180(4):2531-7
references.pmid: 18250463
references.citation: Hepatology. 2006 Jun;43(6):1220-30
references.pmid: 16729305
references.citation: J Pharmacol Exp Ther. 1973 Oct;187(1):185-94
references.pmid: 4746326
references.citation: Toxicol Appl Pharmacol. 2003 Sep 1;191(2):118-29
references.pmid: 12946648
references.citation: Endocrinology. 1998 Mar;139(3):1115-24
references.pmid: 9492045
references.citation: Hepatology. 2002 Jul;36(1):55-64
references.pmid: 12085349
references.citation: Hepatology. 2004 May;39(5):1267-76
references.pmid: 15122755
references.citation: Nat Med. 1996 Jan;2(1):80-6
references.pmid: 8564847
references.citation: J Biol Chem. 1995 Oct 27;270(43):25752-61
references.pmid: 7592757
references.citation: Drug Discov Today. 2007 Apr;12(7-8):336-42
references.pmid: 17395094
references.citation: J Pharmacol Exp Ther. 1973 Oct;187(1):211-7
references.pmid: 4746329
references.citation: Nat Rev Immunol. 2008 Apr;8(4):279-89
references.pmid: 18340345
references.citation: Chem Res Toxicol. 2002 Dec;15(12):1504-13
references.pmid: 12482232
references.citation: Hepatology. 2008 Sep;48(3):889-97
references.pmid: 18712839
references.citation: Gastroenterology. 2007 Jan;132(1):372-83
references.pmid: 17241886
references.citation: Hepatology. 2002 Feb;35(2):289-98
references.pmid: 11826401
references.citation: Nature. 2002 Jul 11;418(6894):191-5
references.pmid: 12110890
references.citation: Hepatology. 2004 Nov;40(5):1170-9
references.pmid: 15486922
references.citation: J Immunol. 2008 Jul 1;181(1):197-207
references.pmid: 18566385
references.citation: Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11942-7
references.pmid: 20547845
references.citation: Life Sci. 2006 Mar 6;78(15):1670-6
references.pmid: 16226279
references.citation: Toxicology. 1992 Nov 1;75(2):97-107
references.pmid: 1281344
references.citation: Gastroenterology. 2004 Dec;127(6):1760-74
references.pmid: 15578514